Biotech Outlook 2013: Top Biotechs Infographic
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
“Biotech industry growth is bolstered by increased R&D spending, an upswing of approved first-in-class medicines, elevated Wall Street valuations, and continued
forging of pipeline alliances with Big Pharma” - 22nd Annual Report: Top 100 Biotechnology Companies, Andrew Humphreys.
In this new infographic Biotech Outlook 2013: Top Biotechs we take a closer look at the top 25 biotechs so far in 2013 and the performance of key industries related to biotech M&A activity.
Have Your Say
Rate this feature and give us your feedback in the comments section below